Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease
- Resource Type
- article
- Source
- CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 8, Pp 1111-1121 (2022)
- Subject
Therapeutics. Pharmacology RM1-950 - Language
- English
- ISSN
- 2163-8306